Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News | Cardiovascular Business

October 2, 2017 — Cardiovascular healthcare membership organization and performance community MedAxiom announced its ...

Home October 02, 2017
Home
News | Heart Valve Technology

October 2, 2017 — Medtronic recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro ...

Home October 02, 2017
Home
Technology | Ventricular Assist Devices (VAD)

September 28, 2017 — Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) ...

Home September 28, 2017
Home
News | Interventional Radiology

September 27, 2017 — Toshiba Medical announced it will highlight several of its latest vascular and interventional ...

Home September 27, 2017
Home
News | Stem Cell Therapies

September 26, 2017 — BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial ...

Home September 26, 2017
Home
News | Vena Cava Filters

September 26, 2017 — The one-year results of the SENTRY clinical trial were presented by principal investigator Michael ...

Home September 26, 2017
Home
News | Heart Failure

September 25, 2017 — BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial ...

Home September 25, 2017
Home
News | Robotic Systems

September 22, 2017 — The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation s ...

Home September 22, 2017
Home
News | Heart Valve Technology

September 21, 2017 — Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for ...

Home September 21, 2017
Home
News | Heart Failure

September 21, 2017 — MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 ...

Home September 21, 2017
Home
News | Heart Failure

September 19, 2017 — The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain ...

Home September 19, 2017
Home
News | Embolic Protection Devices

September 18, 2017 – Claret Medical announced publication of a new study in the Journal of the American College of ...

Home September 18, 2017
Home
News | Hypertension

September 14, 2017 — Marijuana use is associated with a three-fold risk of death from hypertension, according to ...

Home September 14, 2017
Home
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.
Feature | Cath Lab

September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...

Home September 14, 2017
Home
Subscribe Now